-
German consortium hopes to build new fighter jet after FCAS collapse
-
O'Callaghan and Short clock history-making times at Australian trials
-
Trump says Iran 'taken too long to negotiate,' will have to 'pay the price'
-
Pakistan launches deadly strikes on Afghanistan
-
Israel's Netanyahu to seek re-election despite Trump doubts, war strains
-
Stocks drop ahead of key US inflation data
-
6-7, Bad Bunny, AI: Pope targets the young
-
FIFA boss Infantino faces questions on eve of World Cup
-
Iran attacks US bases in Jordan and Bahrain
-
Tech leads Asia losses as rollercoaster week rumbles on
-
Belfast stabbing suspect due in court after night of violence
-
Saudi's new national carrier gets off ground despite war, delays
-
Eddie Jones eyes Mourinho-like laundry stunt to escape ban
-
Bollywood's Imtiaz Ali bets on Gen Z thirst for love
-
Messi plushies see roaring trade as China firms get World Cup boost
-
Messi sparkles on return as Somali referee says World Cup dream over
-
Iran, US trade blows as Middle East peace deal draws no nearer
-
Salt: integral ingredient of sumo stars' art
-
Staal shines as Carolina beat Vegas 5-3 to level Stanley Cup Final
-
Messi scores on injury return as Argentina beat Iceland in World Cup warm-up
-
Art, maths and killing: Ukraine drone chief's formula to stop Russia
-
Tech leads Asia losses, oil rises as rollercoaster week rumbles on
-
Messi set to return as Somali referee says World Cup dream over
-
Former Wallabies skipper Wright signs for Welsh club Ospreys
-
Pope to bless Barcelona's Sagrada Familia, world's tallest church
-
Emotional World Cup return to Mexico for South Africa coach Broos
-
Bill Gates faces questioning in US Congress over Epstein ties
-
'The Donald of Dubai': property tycoon seeks to become data king
-
PGA Tour to co-sanction Australian Open in global push
-
Elon Musk, after DOGE and politics, bets on SpaceX IPO
-
Saudis in World Cup spotlight after $2bn spending spree
-
Mexico doubles down on security before 2026 World Cup
-
US must not be 'too honest' at World Cup, says Roldan
-
Italian astronaut to pilot Artemis III mission
-
North Korea says Xi's visit produced 'far-reaching blueprint' for ties
-
Benfica say farewell to Mourinho as Real Madrid return nears
-
Protesters torch buildings and vehicles, block roads over Belfast stabbing
-
US strikes Iran after Apache helicopter downing
-
Threats to US lawmakers spiked after Meta eased moderation: watchdog
-
Nick Reiner seeks trust fund money for parent murder defense
-
Spain, France qualify for 2027 Women's World Cup as England wait
-
Protesters torch building and vehicles, block roads over Belfast stabbing
-
A woman in charge of the UN? Candidates feel it's about time
-
US tech shares resume sell-off while oil prices retreat
-
Protesters block road to Mexican World Cup stadium
-
White House World Cup chief defends visa ban for Somali referee, Iranians
-
Serena back in the groove on triumphant return to tennis
-
'It doesn't matter': US star Reyna looks past World Cup scandal
-
Somali referee says World Cup 'dream' ruined
-
Knicks ready to 'throw the first punch' in NBA Finals
US Justice Dept takes abortion pill fight to Supreme Court
The US Justice Department said Thursday that it will go to the Supreme Court to appeal restrictions imposed on a widely-used abortion pill in the latest round of an intensifying battle over reproductive rights.
The move by the administration of President Joe Biden came just hours after an appeals court blocked moves to ban mifepristone, but limited access to the drug used for more than half of the abortions in the United States.
"We will be seeking emergency relief from the Supreme Court... to protect Americans' access to safe and effective reproductive care," US Attorney General Merrick Garland said.
Speaking to reporters during Biden's visit to Dublin, Ireland, White House Press Secretary Karine Jean-Pierre said "we believe that the law is on our side, and we will prevail."
Late Wednesday, the US Fifth Circuit Court of Appeals said mifepristone should remain available for now, but limited access to the first seven weeks of pregnancy, down from 10.
The appeals court also said in-person visits would be necessary to obtain the pill -- a requirement lifted in recent years -- and blocked the medication from being sent by mail.
The 2-1 ruling by the conservative-majority federal appeals court in New Orleans, Louisiana, came after a US District Court judge in Texas overturned the Food and Drug Administration's two-decades old approval of the drug last Friday.
The appeals court ruling was denounced by Planned Parenthood, the ACLU, the Center for Reproductive Rights and other groups seeking to maintain access to abortion.
"We are furious that yet another court would choose to jeopardize the health and futures of the millions of people who rely on mifepristone for abortion care," said Planned Parenthood president Alexis McGill Johnson.
Jennifer Dalven, director of the ACLU Reproductive Freedom Project, said "unless the Supreme Court steps in, this decision will prevent many people from getting abortion care and force them to remain pregnant against their will."
- 'Win' -
The anti-abortion group Susan B. Anthony described the latest ruling by two judges appointed by former Republican president Donald Trump as a "win."
"The court recognized that the abortion pill is dangerous and rolled back Biden's reckless mail-order abortion scheme," said Susan B. Anthony state policy director Katie Daniel. "We look forward to the Supreme Court hearing this case."
The latest standoff over women's reproductive freedom in America comes almost a year after the conservative-dominated Supreme Court overturned the landmark Roe v. Wade ruling that had enshrined the constitutional right to abortion for half a century.
Mifepristone is one component of a two-drug regimen that can be used in the United States through the first 10 weeks of pregnancy.
It has a long safety record, and the FDA estimates 5.6 million Americans have used it to terminate pregnancies since it was approved.
Last week's ruling by Judge Matthew Kacsmaryk, also a Trump appointee, imposing a nationwide ban on mifepristone came in response to a suit by a coalition of anti-abortion groups.
The judge, in his decision, adopted language used by abortion opponents, referring to abortion providers as "abortionists" and saying the drug was used to "kill the unborn human."
Kacsmaryk said the two-drug regimen that includes mifepristone had resulted in "thousands of adverse events suffered by women and girls," including intense bleeding and psychological trauma.
But the FDA, researchers and the drugmaker say decades of experience have proven the medication to be safe and effective when used as indicated.
Shortly after the initial Texas decision, a judge in Washington state ruled in a separate case that access to mifepristone must be preserved.
Polls repeatedly show a clear majority of Americans support continued access to safe abortion, even as conservative groups push to limit access the procedure -- or ban it outright.
O.Salim--SF-PST